We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Generic Drug Maker Defers Antitrust Prosecution, Pays $7.32M In Settlements

(June 3, 2019, 10:58 AM EDT) -- PHILADELPHIA — Generic drug maker Heritage Pharmaceuticals Inc. entered into a deferred prosecution agreement on a criminal charge of price fixing and agreed to pay a total of $7.32 million for...
To view the full article, register now.